{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/167123359"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "There are no data on the best time to add oral therapies to lifestyle modifications; thus, to avoid an unacceptable burden on patients, other complicating factors should be considered, such as life expectancy of the patient, presence or absence of microvascular and macrovascular complications, risk for adverse events related to glucose control, and patient preferences." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "guideline.gov" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/255958433"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/167123359"] } } }
